Carla Palleis, MD - Department of Neurology, Ludwig-Maximilians-University, Munich, Germany, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
Matthias Brendel, MD - Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
Anika Finze - Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich, Germany
Endy Weidinger, MD - Department of Neurology, Ludwig-Maximilians-University, Munich, Germany, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
Kai Bötzel, MD - Department of Neurology, Ludwig-Maximilians-University, Munich, Germany
Adrian Danek, MD - Department of Neurology, Ludwig-Maximilians-University, Munich, Germany
Leonie Beyer, MD - Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich, Germany
Alexander Nitschmann - Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich, Germany
Maike Kern - Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich, Germany
Gloria Biechele - Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich, Germany
Boris-Stephan Rauchmann, MD - Department of Radiology, Ludwig-Maximilians-University, Munich, Germany, Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany
Jan Häckert, MD - Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany
Matthias Höllerhage, MD - Department of Neurology, Hannover Medical School, Hannover, Germany
Andrew W. Stephens, MD, PhD - Life Molecular Imaging GmbH, Berlin, Germany
Alexander Drzezga, MD - Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany, German Center for Neurodegenerative Diseases (DZNE), Bonn-Cologne, Germany, Institute of Neuroscience and Medicine (INM-2), Molecular Organization of the Brain, Forschungszentrum Jülich, Julich, Germany
Thilo van Eimeren, MD - Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany, German Center for Neurodegenerative Diseases (DZNE), Bonn-Cologne, Germany, Department of Neurology, University Hospital Cologne, Cologne, Germany
Victor L. Villemagne, MD - Department of Psychiatry, The University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Andreas Schildan, PhD - Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany
Henryk Barthel, MD - Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany
Marianne Patt, PhD - Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany
Osama Sabri, MD - Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany
German Imaging Initiative for Tauopathies (GII4T)
Peter Bartenstein, MD - Department of Nuclear Medicine, Ludwig-Maximilians-University, Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
Robert Perneczky, MD - German Center for Neurodegenerative Diseases (DZNE), Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany, Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany, Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College, London, United Kingdom
Christian Haass, PhD - German Center for Neurodegenerative Diseases (DZNE), Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany, Chair of Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-University, Munich, Germany
Johannes Levin, MD - Department of Neurology, Ludwig-Maximilians-University, Munich, Germany, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
Günter U. Höglinger, MD - German Center for Neurodegenerative Diseases (DZNE), Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany, Department of Neurology, Hannover Medical School, Hannover, Germany

Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.

Upon completion of this activity learners will be able to:

1. Understand the association of corticobasal syndrome with cerebral protein aggregates
2. Assess how imaging can be a useful biomarker for the evaluation of corticobasal syndrome
3. Evaluate the results and how [¹⁸F]PI-2620 may potentially serve for a differential diagnosis and for monitoring disease progression

This activity is intended for physicians, fellows or other practitioners in the field of Movement Disorders with an emphasis on current practice trends.

Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.

All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.

Sara Schaefer: Course Director
Nothing to Disclose

Veronica Santini: Reviewer
Grant: Insightec, Biogen, Roche / Genentech

Carla Palleis: Author
Nothing to disclose

Matthias Brendel: Author
Speaker honoraria from GE Healthcare and LMI and is an adviser of LMI

Anika Finze: Author
Nothing to disclose

Endy Weidinger: Author
Nothing to disclose

Kai Bötzel: Author
Nothing to disclose

Adrian Danek: Author
Nothing to disclose

Leonie Beyer: Author
Nothing to disclose

Alexander Nitschmann: Author
Nothing to disclose

Maike Kern: Author
Nothing to disclose

Gloria Biechele: Author
Nothing to disclose

Boris-Stephan Rauchmann: Author
Nothing to disclose

Jan Häckert: Author
Nothing to disclose

Matthias Höllerhage: Author
Nothing to disclose

Andrew W. Stephens: Author
Employee: LMI

Alexander Drzezga: Author
Nothing to disclose

Thilo van Eimeren: Author
Nothing to disclose

Victor L. Villemagne: Author
Nothing to disclose

Andreas Schildan: Author
Nothing to disclose

Henryk Barthel: Author
Nothing to disclose

Marianne Patt: Author
Nothing to disclose

Osama Sabri: Author
Research funding: LMI

German Imaging Initiative for Tauopathies (GII4T): Author
Nothing to disclose

Peter Bartenstein: Author
Nothing to disclose

Robert Perneczky: Author
Advisory board: Biogen; Consultant: Eli Lilly; Grant Recipient: Janssen Pharmaceutica and Boehringer Ingelheim; Speaker honoraria: Janssen-Cilag, Pfizer, and Biogen

Christian Haass: Author
Chief Scientific Adviser of ISAR Biosciences; Collaboration: DENALI Therapeutics

Johannes Levin: Author
Speaker fee: Bayer Vital; Consulting fee: Axon Neuroscience; Author fee: Thieme medical publishers and W. Kohlhammer GmbH medical publishers; Nonfinancial support: AbbVie, Part-time CMO from MODAG GmbH, all outside the submitted work

Günter U. Höglinger: Author
Research collaboration: Prothena; Consultant: AbbVie, AlzProtect, Asceneuron, Biogen, Biohaven, Lundbeck, Novartis, Roche, Sanofi, UCB; Honoraria: AbbVie, Bial, Biogen, Bristol Myers Squibb, Roche, Teva, UCB, and Zambon; Patent: PERK Activation for the Treatment of Neurodegenerative Diseases (PCT/EP2015/068734)

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The International Parkinson and Movement Disorder Society designates this education activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

All individuals in control of content for this course are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME.